These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4132876)

  • 1. [Effect of estradiol, diethylstilbestrol, progesterone, and gestonorone capronate (depostat) on the 5 alpha-reductase kinetics in benign prostatic hypertrophy (BPH) (author's transl)].
    Altwein JE; Rubin A; Klose K; Knapstein P; Orestano F
    Urologe A; 1974 Jan; 13(1):41-6. PubMed ID: 4132876
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of gestonoron-capronate (GC) upon uptake and metabolism of H3-testosteron in benign prostatic hypertrophy (BPH): in vivo-experiments (author's transl)].
    Orestano F; Bandhauer K; Altwein JE
    Urologe A; 1974 Nov; 13(6):289-92. PubMed ID: 4141158
    [No Abstract]   [Full Text] [Related]  

  • 4. Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations.
    Orestano F; Altwein JE; Knapstein P; Bandhauer K
    J Steroid Biochem; 1975 Jun; 6(6):845-51. PubMed ID: 1177428
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
    Altwein JE; Orestano F; Hohenfellner R
    Invest Urol; 1974 Sep; 12(2):157-61. PubMed ID: 4854628
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
    Govaerts J; van Sande M; Van Camp K
    Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
    [No Abstract]   [Full Text] [Related]  

  • 7. Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate.
    Orestano F; Altwein JE
    Br J Urol; 1976 Dec; 48(6):485-91. PubMed ID: 64267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent results of prostatic adenoma research].
    Kaufmann J
    Z Urol Nephrol; 1975 Nov; 68(11):. PubMed ID: 58501
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol.
    Krieg M; Schlenker A; Voigt KD
    Prostate; 1985; 6(3):233-40. PubMed ID: 2581234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
    Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
    J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and metabolism in vivo of testosterone-1,2-3H by accessory sex organs of male rats; influence of some hormonal compounds.
    Tveter KJ; Aakvaag A
    Endocrinology; 1969 Oct; 85(4):683-9. PubMed ID: 4240878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of treating prostatic adenoma with Depostat].
    Darenkov AF; Zakhvatov IuM; Tanko A; Ignashin NS; Varentsov GI
    Urol Nefrol (Mosk); 1980; (5):34-7. PubMed ID: 6158780
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study.
    Marberger M; Altwein JE; Orestano F
    Invest Urol; 1976 Jan; 13(4):302-6. PubMed ID: 1245393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestagen action on testosterone uptake and metabolism in the rat prostate.
    Smethurst M; Williams DC
    IRCS J Med Sci; 1975 Oct; 3(10):491. PubMed ID: 1165169
    [No Abstract]   [Full Text] [Related]  

  • 15. Depostat for benign prostatic hyperplasia?
    Drug Ther Bull; 1973 Sep; 11(19):75-6. PubMed ID: 4130364
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of stilbestrol on the metabolism of testosterone by benign prostatic hyperplasia in organ culture.
    McMahon MJ; Thomas GH
    Br J Surg; 1971 Nov; 58(11):869. PubMed ID: 4108125
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative treatment of benign prostatic hyperplasia (author's transl)].
    Schoenenberger A; Hauri D
    Ther Umsch; 1982 Apr; 39(4):260-7. PubMed ID: 6179177
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonistic action of anti-androgens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate.
    Fang S; Liao S
    Mol Pharmacol; 1969 Jul; 5(4):428-31. PubMed ID: 5816873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
    Baranowska B; Kuzaka B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.